← Back to Stock Screener← Stock Screener

ZYBERNO

Stock Report

Updated Aug 31, 2026

NeoGenomics, Inc. (NEO)

NASDAQ

$18.05

Professional Investment Analysis

ZYBERNO SCORE →

Is it a great business? Is it getting better?

27.0/100

POOR BUSINESS

NeoGenomics, Inc. (NEO) scores 27/100 — concerning metrics indicating significant structural or financial risks.

📊 How is the Zyberno Score calculated? +

The Zyberno Score answers one question: "Is this a quality business worth owning?" It's a 0-100 investment grade that evaluates business fundamentals across four critical dimensions, based on principles from Warren Buffett, Benjamin Graham, Peter Lynch, and Charlie Munger.

The 4 Core Categories (25 points each):

1. PROFITABILITY (25 pts)

Metrics: ROE, ROIC, Net Margin, Operating Margin
Thresholds: ROE >20% excellent • ROIC >20% excellent • Net Margin >20% excellent • Operating Margin >25% excellent

2. FINANCIAL STRENGTH (25 pts)

Metrics: Debt-to-Equity, Current Ratio, Interest Coverage, Altman Z-Score
Thresholds: D/E <0.3 excellent • Current Ratio >2.5 excellent • Interest Coverage >10x excellent • Altman Z >3.0 safe

3. CASH FLOW QUALITY (25 pts)

Metrics: Free Cash Flow, OCF vs Net Income, FCF Margin
Thresholds: Positive & growing FCF excellent • OCF/NI >1.2x excellent (cash earnings exceed accounting)

4. GROWTH & CONSISTENCY (25 pts)

Metrics: Revenue Growth, Net Income Growth, FCF Growth, Piotroski F-Score
Thresholds: Growth via log-linear regression • Piotroski 8-9 excellent, 6-7 good

Score Interpretation:

75-100

GREAT BUSINESS

65-74

GOOD BUSINESS

50-64

AVERAGE BUSINESS

30-49

WEAK BUSINESS

0-29

POOR BUSINESS

→ View full NEO quality analysis & detailed breakdown

VALUATION SIGNAL

N/A (Requires more data)

Requires fair value calculation and current price data

💰 How is Margin of Safety calculated? +

Margin of Safety measures how much discount or premium you're paying relative to a stock's intrinsic value. It's Benjamin Graham's core principle: the larger the margin, the lower your downside risk.

Formula: (Intrinsic Value − Current Price) ÷ Intrinsic Value × 100%

How We Calculate Intrinsic Value (DCF Method):

Step 1: Calculate current Owner Earnings (OCF − Maintenance CapEx)

Step 2: Calculate company-specific growth rate using log-linear regression on 16 quarters of Owner Earnings

Step 3: Project 10 years forward using the calculated growth rate

Step 4: Discount each year's cash flow to present value using 10% discount rate

Step 5: Calculate terminal value using 3% perpetual growth rate

Step 6: Sum all discounted cash flows = Intrinsic Value

What The Percentages Mean:

+50% or more

EXCELLENT — Very undervalued

+25% to +50%

GOOD — Attractive discount

0% to +25%

FAIR — Reasonable value

0% to -25%

CAUTION — Slight premium

-25% or worse

POOR — Overvalued

"Price is what you pay, value is what you get." — Warren Buffett

→ View full NEO valuation analysis · → View full NEO Brina Gap analysis

📈 How is Brina Gap calculated? +

Brina Gap measures the difference between the growth a business can fundamentally sustain and the growth the market is already pricing in.

Formula: Fundamental Growth Rate − Market-Implied Growth Rate

The Two Components:

Fundamental Growth Rate = ROIC × Reinvestment Rate

What the business can sustainably grow at based on how much it reinvests and what return it earns on that capital. Grounded in historical financials.

Market-Implied Growth Rate = Reverse DCF

The growth rate the current Enterprise Value implicitly assumes. Calculated by back-solving a 10-year DCF model (10% WACC, 3% terminal growth) until the present value of projected cash flows equals EV.

What The Gap Means:

Gap > +5% Market Underestimates — potential upside

+2% to +5% Slight Underestimate

-2% to +2% Fairly Priced — market consensus matches fundamentals

-5% to -2% Slight Overestimate

Gap < -5% Market Overestimates — price embeds optimism fundamentals don't support

A positive gap (market underestimates) combined with a positive Margin of Safety is the strongest combined signal — the business is both cheap historically and forward economics are stronger than the price suggests.

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-6.3%)

Debt-to-Equity (Solvency Risk):EXCELLENT (0.19x)

Operating Margin (Operational Efficiency):CRITICAL (-8.9%)

Return on Capital (Capital Efficiency):CRITICAL (-5.0%)

📊 Valuation Trilogy

Three interconnected metrics for complete valuation analysis

Click any metric for full methodology and detailed analysis

Zyberno's Verdict

NeoGenomics, Inc. (NEO) stock report — Zyberno Score 27/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, NEO generated -$4.17M in Owner Earnings. Capital was deployed as follows: $27.51M invested in capital expenditures. Reinvestment rate: -3.3%.

DIVISION I: EXECUTIVE SUMMARY

A. Market Valuation

Market Price & Capitalization (2)

Current Price:18.05

Market Cap:$2.34B

Valuation Multiples (3)

P/B Ratio:2.98x

P/S Ratio:3.05x

Peg Ratio:-999.00x

Enterprise Metrics (2)

Enterprise Value:$2.57B

Ev Ebitda Ratio:118.54x

Price Action & Momentum (3)

12-1 Momentum:

+171.5% (92th pctile)

📈 Click to view full NEO Momentum analysis →

Momentum Percentile:92 / 100

% of 52-Week High:103.4%

B. Profitability Assessment

Return Metrics (5)

ROE:

-6.3%

📊 Click to view full NEO ROE analysis →

ROA:-3.8%

Roic:

-5.0%

📊 Click to view full NEO ROIC analysis →

Reinvestment Rate:-3.3%

Fundamental Growth Rate (g):0.2%

Margin Analysis (3)

Operating Margin Ttm:-8.9%

Net Margin Ttm:-6.8%

Ebitda Margin:2.8%

TTM Performance (3)

Gross Margin Ttm:43.9%

Operating Margin Ttm:-8.9%

Net Margin Ttm:-6.8%

Yield Metrics (2)

Earnings Yield:-$2.22

Dividend Yield:0.0%

C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

Earnings Surprise (SUE):

+1.70

📊 Click to view full NEO Earnings Surprise analysis →

EPS Surprise vs Expected:105.3%

Latest Earnings Filed:2026-07-28

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):11.4%

Cash Flow Growth (Linear) (2)

Free Cash Flow Growth Rate (Linear):-41.8%

Operating Cash Flow Growth Rate (Linear):-50.0%

D. Financial Stability

Liquidity Ratios (3)

Current Ratio:3.60x

Quick Ratio:3.35x

Cash Ratio:1.37x

Leverage Analysis (3)

Debt To Equity Ttm:0.19x

Debt-to-Equity Ratio:0.19x

Debt To Ebitda:17.42x

Coverage Ratios (2)

Interest Coverage Ratio:-44.90x

Times Interest Earned:-44.90

Capital Structure (4)

Working Capital:275,595,000.00

Cash And Cash Equivalents:145,539,000.00

Long Term Debt:$374.24M

Net Debt:$232.42M

DIVISION II: FINANCIAL STATEMENTS ANALYSIS

A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $766.30M

Linear Growth: 11.4%

📊 Click to view full NEO Revenue analysis & methodology →

Cost Of Revenue Ttm:$429.76M

Profitability Breakdown (2)

Gross profit TTM: $336.53M

Linear Growth: 15.0%

📊 Click to view full NEO Gross Profit analysis & methodology →

-$68.44M

Bottom Line Performance (3)

-$51.88M

Income Before Tax:-$54.55M

Ebitda Ttm:21,699,000.00

Operating Expenses (5)

Operating Expenses:404,971,000.00

R And D Expense:38,168,000.00

Sga Expense:262,737,000.00

Income Tax Expense:-$2.67M

Interest Expense:2,581,000.00

Expense Ratios (3)

R And D To Revenue Percentage:18.9%

Sga To Revenue Percentage:130.3%

Ebitda Margin:2.8%

B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$1.35B

Current Assets:$381.48M

Ppe Net:80,938,000.00

Goodwill:523,995,000.00

Intangible Assets:$271.26M

Liability Structure (4)

Total Liabilities:566,511,000.00

Current Liabilities:105,883,000.00

Long Term Debt:$374.24M

Short Term Debt:$3.72M

Equity & Capital (3)

Equity:$785.73M

Retained Earnings:-$448.67M

Common Stock:250,000,000.00

Working Capital Items (3)

Accounts Receivable:175,405,000.00

Inventory:27,137,000.00

Accounts Payable:20,953,000.00

Special Items (2)

Contract Liabilities:528,000.00

Stock Based Compensation:8,216,000.00

C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: $22.42M

Linear Growth: -50.0%

Free cash flow TTM: -$5.09M

Linear Growth: -41.8%

📊 Click to view full NEO Free Cash Flow analysis & methodology →

Investment Activities (2)

Investing Cash Flow:-$5.00M

Capital Expenditures Ttm:27,508,000.00

Financing Activities (3)

Financing Cash Flow:-$338.00K

Dividends Paid Ttm:0.00

Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:-338,000.00

Long Term Debt Issuance:$0.00

Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:90,139,000.00

DIVISION III: OPERATIONAL METRICS

A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.40

-$0.40

Earnings Per Share Ttm:-$0.40

Revenue & Cash Per Share (2)

Sales Per Share Ttm:5.91

Operating Cash Flow Per Share:$0.04

Book Value & Capital (2)

Book Value Per Share:$6.06

Cash Per Share:1.12

Dividend Policy (1)

Dividend Payout Ratio:-999.00x

B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.56x

Working Capital Turnover Ttm:2.78x

Receivables Management (2)

Receivables Turnover Ttm:4.37x

Days Sales Outstanding Ttm:83.55

Inventory Management (2)

Inventory Turnover Ttm:15.84x

Days Inventory Outstanding Ttm:23.05

Payables & Cash Cycle (2)

Days Payable Outstanding:17.80

Cash Conversion Cycle:88.80

C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:80.00

Quality Score:45.00

Market Metrics (2)

Beta:0.00x

Volatility Category:unknown

DIVISION IV: INVESTMENT ANALYSIS

A. Value Investment Framework

Owner Earnings Analysis (1)

-$4.17M

Damodaran Growth Analysis (2)

Reinvestment Rate:-3.3%

Fundamental Growth Rate (g):0.2%

B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):11.4%

Cash Flow Growth Rates (2)

Free Cash Flow Growth Rate (Linear):-41.8%

Operating Cash Flow Growth Rate (Linear):-50.0%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):15.0%

Book Value Growth Rate (Linear):-6.1%

C. Company Profile & Context

Corporate Information (6)

Symbol:NEO

Company Name:NeoGenomics, Inc.

Sector:Unknown

Industry:Services-Testing Laboratories

Exchange:NASDAQ

Country:United States

Market Classification (3)

Market Cap Category:N/A

Price Category:medium

Volume Category:N/A

Share Structure (3)

Shares Outstanding:129.63M

Shares Outstanding Basic:129.63M

Shares Outstanding Diluted:130.83M

Data Processing Info (3)

Processing Version:v3.0

Last Updated:2026-08-31 15:57:09 UTC

Data Timestamp:2026-08-31T15:57:09.644708